Skip to main content

Table 2 Treatment-related adverse events possibly or probably related to INTUVAX after first and second vaccination

From: Intratumorally injected pro-inflammatory allogeneic dendritic cells as immune enhancers: a first-in-human study in unfavourable risk patients with metastatic renal cell carcinoma

Reported Adverse event

No of related AEs (no. of patients)

CTCAE-grade (range)

Fever

8 (5)

1–2

Chills

2 (2)

1

Rash

1 (1)

1

Hypotension

1 (1)

2

Back to article page